Skip to content
“I think we’re in a very exciting time in healthcare and biotech,” said Steven Ladd, Director of Business Development and Acquisitions at AbbVie. “It’s […]
China-U.S. biotech ventures are where collaboration meets competition Read More »
On Friday, the Biotechnology Innovation Organization (BIO) submitted biotech regulation comments on the Administration’s Request for Information (RFI) “Identifying Ambiguities, Gaps, Inefficiencies, and Uncertainties in
BIO submits comments on framework for biotech regulation Read More »
The narrative is that it’s a bad market for biotech, but CEOs and investors told a packed house at the 2023 BIO CEO and
Are SPACs dead? – and other questions about the biotech market outlook Read More »
On Day 1 of the BIO CEO and Investor Conference, a panel—Prioritizing CRO Spending Through a High-Inflation, Sparse-Funding Period—brought together experts to look at
5 things to know about clinical trials Read More »
With the 118th Congress picking up steam, the Biotechnology Innovation Organization’s (BIO) Federal Government Relations team shared what to expect in health care and
What BIO’s watching on health care and agriculture policy in 2023 Read More »
“It’s exciting times,” said Kathy Fernando, Senior Vice President and Global Head of the Partner of Choice Organization at Pfizer Inc. Speaking about the
Pfizer Ignite’s new model is turning heads and sharing the wealth Read More »
David Thomas and Chad Wessel of the Biotechnology Innovation Organization’s (BIO) Industry Analysis team, authors of The State of Innovation in Pain and Addiction,
Investment in new pain and addiction treatments falls short, says BIO study Read More »
The teams behind Good Day BIO and Bio.News is live at the BIO CEO and Investor Conference in New York. The Marriott Marquis in
How to follow the BIO CEO and Investor Conference 2023 Read More »
The World Health Organization (WHO) suggests additional waivers of intellectual property rights during the next pandemic in the initial draft of its global pandemic
Draft WHO pandemic treaty suggests future IP waivers Read More »
The intellectual property protections that enabled the record-setting development of COVID-19 vaccines and treatments require rigorous federal protection, says the Biotechnology Innovation Organization (BIO)
BIO recommends 11 countries for USTR’s Priority Watch List Read More »
